The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ABEONA THERAPEUTICS INC | COM | 00289Y107 | 3,213 | 450,000 | SH | SOLE | 450,000 | 0 | 0 | ||
| ACADIA PHARMACEUTICALS INC | COM | 004225108 | 3,153 | 195,000 | SH | SOLE | 195,000 | 0 | 0 | ||
| AIMMUNE THERAPEUTICS INC | COM | 00900T107 | 3,588 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
| AMARIN CORP PLC | SPONSORED ADR | 023111206 | 17,012 | 1,250,000 | SH | SOLE | 1,250,000 | 0 | 0 | ||
| APELLIS PHARMACEUTICALS INC | COM | 03753U106 | 3,627 | 275,000 | SH | SOLE | 275,000 | 0 | 0 | ||
| ARDELYX INC | COM | 04269E107 | 358 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
| ASSERTIO THERAPEUTICS INC | COM | 04545L107 | 433 | 120,000 | SH | SOLE | 120,000 | 0 | 0 | ||
| AUDENTES THERAPEUTICS INC | COM | 05070R104 | 5,330 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
| AVENUE THERAPEUTICS INC | COM NEW | 05360L205 | 2,678 | 496,000 | SH | SOLE | 496,000 | 0 | 0 | ||
| AXOGEN INC | COM | 05463X106 | 26,559 | 1,300,000 | SH | SOLE | 1,300,000 | 0 | 0 | ||
| AXOVANT SCIENCES | COM | G0750W104 | 577 | 580,000 | SH | SOLE | 580,000 | 0 | 0 | ||
| BIOLINERX LTD | SPONSORED ADR | 09071M106 | 109 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
| BLUEPRINT MEDICINES CORP | COM | 09627Y109 | 16,173 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
| CERECOR INC | COM | 15671L109 | 6,212 | 2,185,536 | SH | SOLE | 2,185,536 | 0 | 0 | ||
| CHIMERIX INC | COM | 16934W106 | 5,191 | 2,020,000 | SH | SOLE | 2,020,000 | 0 | 0 | ||
| CIDARA THERAPEUTICS INC | COM | 171757107 | 2,820 | 1,200,000 | SH | SOLE | 1,200,000 | 0 | 0 | ||
| CLEMENTIA PHARMACEUTICALS INC | COM | 185575107 | 1,764 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
| CODEXIS INC | COM | 192005106 | 29,225 | 1,750,000 | SH | SOLE | 1,750,000 | 0 | 0 | ||
| COLLEGIUM PHARMACEUTICALS INC | COM | 19459J104 | 1,373 | 80,000 | SH | SOLE | 80,000 | 0 | 0 | ||
| CTI BIOPHARMA CORP | COM | 12648L601 | 1,027 | 1,400,000 | SH | SOLE | 1,400,000 | 0 | 0 | ||
| CYMABAY THERAPEUTICS INC | COM | 23257D103 | 5,705 | 725,000 | SH | SOLE | 725,000 | 0 | 0 | ||
| DECIPHERA PHARMACEUTICALS IN | COM | 24344T101 | 7,136 | 340,000 | SH | SOLE | 340,000 | 0 | 0 | ||
| DERMIRA INC | COM | 24983L104 | 539 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | ||
| EIDOS THERAPEUTICS INC | COM | 28249H104 | 1,926 | 140,000 | SH | SOLE | 140,000 | 0 | 0 | ||
| EPIZYME INC | COM | 29428V104 | 6,930 | 1,125,000 | SH | SOLE | 1,125,000 | 0 | 0 | ||
| ETON PHARMACEUTICALS INC | COM | 29772L108 | 3,200 | 523,000 | SH | SOLE | 523,000 | 0 | 0 | ||
| FENNEC PHARMACEUTICALS INC | COM | 31447P100 | 5,742 | 900,000 | SH | SOLE | 900,000 | 0 | 0 | ||
| FIBROGEN INC | COM | 31572Q808 | 9,256 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
| IMMUNOGEN INC | COM | 45253H101 | 4,900 | 1,021,000 | SH | SOLE | 1,021,000 | 0 | 0 | ||
| IMPRIMIS PHARMACEUTICALS INC | COM | 45323A201 | 9,798 | 1,722,000 | SH | SOLE | 1,722,000 | 0 | 0 | ||
| LOXO ONCOLOGY INC | COM | 548862101 | 24,512 | 175,000 | SH | SOLE | 175,000 | 0 | 0 | ||
| MACROGENICS INC | COM | 556099109 | 1,905 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
| MAGENTA THERAPEUTICS INC | COM | 55910K108 | 2,878 | 505,000 | SH | SOLE | 505,000 | 0 | 0 | ||
| MIRAGEN THERAPEUTICS INC | COM | 60463E103 | 1,166 | 385,000 | SH | SOLE | 385,000 | 0 | 0 | ||
| ODONATE THERAPEUTICS INC | COM | 676079106 | 690 | 49,000 | SH | SOLE | 49,000 | 0 | 0 | ||
| POLARITYTE INC | COM | 731094108 | 5,396 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
| PROTALIX BIOTHERAPEUTICS INC | COM | 74365A101 | 777 | 2,500,000 | SH | SOLE | 2,500,000 | 0 | 0 | ||
| PTC THERAPEUTICS INC | COM | 69366J200 | 6,520 | 190,000 | SH | SOLE | 190,000 | 0 | 0 | ||
| PUMA BIOTECHNOLOGY INC | COM | 74587V107 | 2,035 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
| SANGAMO BIOSCIENCES INC | COM | 800677106 | 5,740 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
| STRONGBRIDGE BIOPHARMA PLC | COM | G85347105 | 6,227 | 1,390,000 | SH | SOLE | 1,390,000 | 0 | 0 | ||
| TG THERAPEUTICS INC | COM | 88322Q108 | 2,255 | 550,000 | SH | SOLE | 550,000 | 0 | 0 | ||
| TRICIDA INC | COM | 89610F101 | 2,900 | 123,000 | SH | SOLE | 123,000 | 0 | 0 | ||
| VIKING THERAPEUTICS INC | COM | 92686J106 | 6,311 | 825,000 | SH | SOLE | 825,000 | 0 | 0 | ||
| XENCOR INC | COM | 98401F105 | 6,508 | 180,000 | SH | SOLE | 180,000 | 0 | 0 | ||
| XOMA CORP DEL | COM NEW | 98419J206 | 5,060 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
| ZYMEWORKS INC | COM | 98985W102 | 1,541 | 105,000 | SH | SOLE | 105,000 | 0 | 0 | ||